Drug Manufacturers - Specialty & Generic | Healthcare
Alivus Life Sciences Limited engages in the development, manufacture, and marketing of non-commoditized active pharmaceutical ingredients for various chronic therapeutic areas in India. The company offers various APIs, such as olmesartan, telmisartan, perindopril, atovaquone, solifenacin, mirabegron, sitagliptin, zonisamide, adapalene, and rosuvastatin. It also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. The company's APIs are used in various therapeutic segments, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, and anti-infectives. It also exports its products to Europe, North America, Latin America, Japan, and internationally. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was incorporated in 2011 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
Market Cap
124413370368
Current Price
1007.2
52 Week Range
850.0 - 1251.0
Previous Close
1007.3
Open
1002.6
Sector
Healthcare
Address
OIA House, 4th Floor 470, Cardinal Gracious Road Andheri (East), Mumbai, 400099, India
Phone
+91-22682-97979
Website
https://www.alivus.com
Day Low
1002.6
Day High
1010.8
Dividend Yield
PE Ratio
25.706993
Earnings Per Share
39.18
Beta
0.157
EBITDA
6825840128
Book Value
229.77
EPS
44.4
Name | Title | Age | Year Born |
---|---|---|---|
Dr. Yasir Yusufali Rawjee Ph.D. | CEO, MD & Director | 59 | 1965 |
Mr. Tushar P. Mistry | Senior VP & CFO | - | - |
Mr. Vinod Naik | Group VP, Head of Technical Operations & Whole Time Director | - | - |
Mr. Rudalf Corriea | Company Secretary & Compliance Officer | - | - |
Soumi Rao | General Manager of Corporate Communications | - | - |
Mr. Sumantra Mitra | Senior VP & Head of Human Resources | - | - |
Mr. Mathew George | Senior VP & Head of Regulatory Affairs | - | - |
Mr. Navin Kumar Agrawal | VP & Head of Corporate Quality | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.